Anika Therapeutics, Inc. Comprehensive Income
Anika Therapeutics, Inc. (ANIK) reported Comprehensive Income of $3.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-29
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $3.29M.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$5.41M.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $272.00K.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$2.51M.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$9.06M.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$57.23M.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$82.17M.
- Anika Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$15.58M, a 626.84% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.29M 10-Q · filed 2026-07-29 | -$2.12M 10-Q · filed 2026-07-29 | -$1.84M derived: sum of 3 quarters · filed 2026-07-29 | -$4.36M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | -$5.41M 10-Q · filed 2026-04-30 | -$5.13M derived: sum of 2 quarters · filed 2026-04-30 | -$7.65M derived: sum of 3 quarters · filed 2026-04-30 | -$10.27M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.24M derived: sum of 2 quarters · filed 2026-03-03 | -$4.86M derived: sum of 3 quarters · filed 2026-07-29 | -$9.06M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | -$2.51M 10-Q · filed 2025-11-05 | -$5.13M derived: sum of 2 quarters · filed 2026-07-29 | -$9.33M 10-Q · filed 2025-11-05 | -$32.27M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$2.62M 10-Q · filed 2026-07-29 | -$6.82M 10-Q · filed 2026-07-29 | -$29.76M derived: sum of 3 quarters · filed 2026-07-29 | -$58.97M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | -$4.19M 10-Q · filed 2026-04-30 | -$27.14M derived: sum of 2 quarters · filed 2026-04-30 | -$56.34M derived: sum of 3 quarters · filed 2026-04-30 | -$56.53M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$52.15M derived: sum of 2 quarters · filed 2026-03-03 | -$52.34M derived: sum of 3 quarters · filed 2026-03-03 | -$57.23M 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | -$29.20M 10-Q · filed 2025-11-05 | -$29.39M derived: sum of 2 quarters · filed 2025-11-05 | -$34.28M 10-Q · filed 2025-11-05 | -$96.66M derived: sum of 4 quarters · filed 2026-03-03 | ||||
| 2024-06-30 | -$189.00K 10-Q · filed 2025-07-30 | -$5.08M 10-Q · filed 2025-07-30 | -$67.45M derived: sum of 3 quarters · filed 2026-03-03 | -$74.44M derived: sum of 4 quarters · filed 2026-03-03 | ||||
| 2024-03-31 | -$4.89M 10-Q · filed 2025-05-09 | -$67.27M derived: sum of 2 quarters · filed 2026-03-03 | -$74.25M derived: sum of 3 quarters · filed 2026-03-03 | -$76.97M derived: sum of 4 quarters · filed 2026-03-03 | ||||
| 2023-12-31 | -$62.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$69.36M derived: sum of 2 quarters · filed 2026-03-03 | -$72.09M derived: sum of 3 quarters · filed 2026-03-03 | -$82.17M 10-K · filed 2026-03-03 | ||||
| 2023-09-30 | -$6.98M 10-Q · filed 2024-11-04 | -$9.71M derived: sum of 2 quarters · filed 2024-11-04 | -$19.79M 10-Q · filed 2024-11-04 | -$23.64M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$2.73M 10-Q · filed 2024-08-08 | -$12.80M 10-Q · filed 2024-08-08 | -$16.66M derived: sum of 3 quarters · filed 2025-03-17 | -$21.68M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$10.08M 10-Q · filed 2024-05-08 | -$13.93M derived: sum of 2 quarters · filed 2025-03-17 | -$18.96M derived: sum of 3 quarters · filed 2025-03-17 | -$22.65M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$8.88M derived: sum of 2 quarters · filed 2025-03-17 | -$12.57M derived: sum of 3 quarters · filed 2025-03-17 | -$15.58M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | -$5.03M 10-Q · filed 2023-11-03 | -$8.72M derived: sum of 2 quarters · filed 2023-11-03 | -$11.73M 10-Q · filed 2023-11-03 | -$17.92M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | -$3.69M 10-Q · filed 2023-08-08 | -$6.70M 10-Q · filed 2023-08-08 | -$12.90M derived: sum of 3 quarters · filed 2024-03-15 | -$12.14M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | -$3.01M 10-Q · filed 2023-05-09 | -$9.21M derived: sum of 2 quarters · filed 2024-03-15 | -$8.45M derived: sum of 3 quarters · filed 2024-03-15 | -$1.72M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | -$6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$5.43M derived: sum of 2 quarters · filed 2024-03-15 | $1.29M derived: sum of 3 quarters · filed 2024-03-15 | $2.96M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $757.00K 10-Q · filed 2022-11-09 | $91.00K 10-Q · filed 2021-11-05 | $7.49M derived: sum of 2 quarters · filed 2022-11-09 | $9.15M 10-Q · filed 2022-11-09 | -$5.09M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | $6.73M 10-Q · filed 2022-08-04 | $9.06M 10-Q · filed 2022-08-04 | -$5.84M derived: sum of 3 quarters · filed 2023-03-16 | -$11.73M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $2.33M 10-Q · filed 2022-05-06 | -$12.57M derived: sum of 2 quarters · filed 2023-03-16 | -$18.46M derived: sum of 3 quarters · filed 2023-03-16 | -$25.96M derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | -$14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$20.79M derived: sum of 2 quarters · filed 2023-03-16 | -$28.29M derived: sum of 3 quarters · filed 2023-03-16 | -$22.63M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | -$5.89M 10-Q · filed 2021-11-05 | -$13.39M derived: sum of 2 quarters · filed 2021-11-05 | -$7.72M 10-Q · filed 2021-11-05 | -$3.25M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | -$7.50M 10-Q · filed 2021-08-06 | -$1.83M 10-Q · filed 2021-08-06 | $2.64M derived: sum of 3 quarters · filed 2022-03-11 | $11.21M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $5.66M 10-Q · filed 2021-05-07 | $10.13M derived: sum of 2 quarters · filed 2022-03-11 | $18.71M derived: sum of 3 quarters · filed 2022-03-11 | $28.29M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $13.05M derived: sum of 2 quarters · filed 2022-03-11 | $22.63M derived: sum of 3 quarters · filed 2022-03-11 | $26.82M 10-K · filed 2022-03-11 | ||||
| 2019-09-30 | $8.58M 10-Q · filed 2020-11-05 | $18.16M derived: sum of 2 quarters · filed 2020-11-05 | $22.35M 10-Q · filed 2020-11-05 | $29.77M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-06-30 | $9.58M 10-Q · filed 2020-08-07 | $13.77M 10-Q · filed 2020-08-07 | $21.19M derived: sum of 3 quarters · filed 2021-04-26 | $28.68M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-03-31 | $4.19M 10-Q · filed 2020-05-22 | $11.61M derived: sum of 2 quarters · filed 2021-04-26 | $19.10M derived: sum of 3 quarters · filed 2021-04-26 | $28.24M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2018-12-31 | $7.42M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26 | $14.91M derived: sum of 2 quarters · filed 2021-04-26 | $24.05M derived: sum of 3 quarters · filed 2021-04-26 | $17.98M 10-K/A · filed 2021-04-26 | ||||
| 2018-09-30 | $7.49M 10-Q · filed 2019-10-28 | $16.63M derived: sum of 2 quarters · filed 2019-10-28 | $10.56M 10-Q · filed 2019-10-28 | $18.89M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-06-30 | $9.14M 10-Q · filed 2019-07-26 | $3.07M 10-Q · filed 2019-07-26 | $11.40M derived: sum of 3 quarters · filed 2020-03-06 | $18.98M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2018-03-31 | -$6.07M 10-Q · filed 2019-05-06 | $2.26M derived: sum of 2 quarters · filed 2020-03-06 | $9.84M derived: sum of 3 quarters · filed 2020-03-06 | $22.50M derived: sum of 4 quarters · filed 2020-03-06 | ||||
| 2017-12-31 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $15.91M derived: sum of 2 quarters · filed 2020-03-06 | $28.57M derived: sum of 3 quarters · filed 2020-03-06 | $34.35M 10-K · filed 2020-03-06 | ||||
| 2017-09-30 | $7.58M 10-Q · filed 2018-10-26 | $20.23M derived: sum of 2 quarters · filed 2018-10-26 | $26.02M 10-Q · filed 2018-10-26 | $32.89M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $12.66M 10-Q · filed 2018-07-31 | $18.44M 10-Q · filed 2018-07-31 | $25.31M derived: sum of 3 quarters · filed 2019-02-27 | $34.57M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $5.79M 10-Q · filed 2018-05-10 | $12.65M derived: sum of 2 quarters · filed 2019-02-27 | $21.92M derived: sum of 3 quarters · filed 2019-02-27 | $30.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $16.13M derived: sum of 2 quarters · filed 2019-02-27 | $24.21M derived: sum of 3 quarters · filed 2019-02-27 | $31.88M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $9.26M 10-Q · filed 2017-10-27 | $17.34M derived: sum of 2 quarters · filed 2017-10-27 | $25.01M 10-Q · filed 2017-10-27 | $35.47M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $8.08M 10-Q · filed 2017-07-28 | $15.75M 10-Q · filed 2017-07-28 | $26.21M derived: sum of 3 quarters · filed 2018-02-27 | $34.85M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $7.67M 10-Q · filed 2017-05-04 | $18.13M derived: sum of 2 quarters · filed 2018-02-27 | $26.77M derived: sum of 3 quarters · filed 2018-02-27 | $35.01M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $19.10M derived: sum of 2 quarters · filed 2018-02-27 | $27.34M derived: sum of 3 quarters · filed 2018-02-27 | $28.60M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $8.64M 10-Q · filed 2016-11-01 | $8.64M 10-Q · filed 2015-11-03 | $16.88M derived: sum of 2 quarters · filed 2016-11-01 | $18.14M 10-Q · filed 2016-11-01 | $18.14M 10-Q · filed 2015-11-03 | $25.06M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $8.24M 10-Q · filed 2016-08-01 | $8.24M 10-Q · filed 2015-08-04 | $9.50M 10-Q · filed 2016-08-01 | $9.50M 10-Q · filed 2015-08-04 | $16.42M derived: sum of 3 quarters · filed 2017-02-24 | $20.91M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $1.27M 10-Q · filed 2016-05-03 | $1.27M 10-Q · filed 2015-05-04 | $8.18M derived: sum of 2 quarters · filed 2017-02-24 | $12.67M derived: sum of 3 quarters · filed 2017-02-24 | $21.79M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $11.41M derived: sum of 2 quarters · filed 2017-02-24 | $20.52M derived: sum of 3 quarters · filed 2017-02-24 | $35.52M 10-K · filed 2017-02-24 | $35.52M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $4.49M 10-Q · filed 2015-11-03 | $13.60M derived: sum of 2 quarters · filed 2015-11-03 | $28.61M 10-Q · filed 2015-11-03 | $35.71M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $9.11M 10-Q · filed 2015-08-04 | $24.12M 10-Q · filed 2015-08-04 | $31.22M derived: sum of 3 quarters · filed 2016-03-10 | $37.09M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $15.00M 10-Q · filed 2015-05-04 | $22.11M derived: sum of 2 quarters · filed 2016-03-10 | $27.98M derived: sum of 3 quarters · filed 2016-03-10 | $34.22M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $12.98M derived: sum of 2 quarters · filed 2016-03-10 | $19.21M derived: sum of 3 quarters · filed 2016-03-10 | $21.53M 10-K · filed 2016-03-10 | $21.53M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $5.87M 10-Q · filed 2014-11-06 | $12.11M derived: sum of 2 quarters · filed 2014-11-06 | $14.43M 10-Q · filed 2014-11-06 | $19.59M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $6.23M 10-Q · filed 2014-08-04 | $8.55M 10-Q · filed 2014-08-04 | $13.72M derived: sum of 3 quarters · filed 2015-03-13 | $15.92M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $2.32M 10-Q · filed 2014-05-05 | $7.48M derived: sum of 2 quarters · filed 2015-03-13 | $9.68M derived: sum of 3 quarters · filed 2015-03-13 | $11.82M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $7.36M derived: sum of 2 quarters · filed 2015-03-13 | $9.50M derived: sum of 3 quarters · filed 2015-03-13 | $12.17M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $2.20M 10-Q · filed 2013-11-05 | $4.34M derived: sum of 2 quarters · filed 2013-11-05 | $7.01M 10-Q · filed 2013-11-05 | $8.60M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $2.14M 10-Q · filed 2013-08-06 | $4.81M 10-Q · filed 2013-08-06 | $6.40M derived: sum of 3 quarters · filed 2014-03-13 | $7.80M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $2.67M 10-Q · filed 2013-05-06 | $4.26M derived: sum of 2 quarters · filed 2014-03-13 | $5.66M derived: sum of 3 quarters · filed 2014-03-13 | $8.54M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $3.00M derived: sum of 2 quarters · filed 2014-03-13 | $5.87M derived: sum of 3 quarters · filed 2014-03-13 | $7.95M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $1.40M 10-Q · filed 2012-11-08 | $4.28M derived: sum of 2 quarters · filed 2012-11-08 | $6.35M 10-Q · filed 2012-11-08 | $6.95M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $2.88M 10-Q · filed 2012-08-07 | $4.95M 10-Q · filed 2012-08-07 | $5.55M derived: sum of 3 quarters · filed 2013-03-14 | $9.82M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $2.07M 10-Q · filed 2012-05-07 | $2.67M derived: sum of 2 quarters · filed 2013-03-14 | $6.94M derived: sum of 3 quarters · filed 2013-03-14 | $5.19M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $599.54K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $4.87M derived: sum of 2 quarters · filed 2013-03-14 | $3.11M derived: sum of 3 quarters · filed 2013-03-14 | $1.77M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $4.27M 10-Q · filed 2011-11-04 | $2.51M derived: sum of 2 quarters · filed 2011-11-04 | $1.17M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | -$1.75M 10-Q/A · filed 2011-08-10 | -$3.10M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $3.69M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |